Novartis to cut 220 jobs as it closes German site
Novartis Announces Job Cuts and Site Closure in Germany
Details of the Site Closure
May 5 (Reuters) - Swiss drugmaker Novartis said on Tuesday that it is set to cut around 220 jobs in Germany as part of the planned closure of a production site by the end of 2028.
Reasons for the Closure
The production site in Wehr, Germany, which manufactures tablets and capsules, is no longer competitive, the Swiss company said in a statement.
Clarification on Related Factors
The planned site closure is not related to Novartis' recent ramp-up in investments into U.S. manufacturing following U.S. tariff threats, nor connected to Germany’s new healthcare measures, Novartis told Reuters separately in an email. The company remains committed to Germany as a location, it added.
(Reporting by Marleen Kaesebier and Maggie Fick; editing by Matthias Williams)
